STOCKHOLM, Sept. 30, 2019 /PRNewswire/ -- Bactiguard has
received a new order from Well Lead Medical (Well Lead) in
China. The order will be delivered
promptly and generate revenues in the third quarter of
approximately SEK 4,8
million.
"The order we have just received from Well Lead is the first
outside of the initial contract and therefore an important
milestone in our cooperation, as it shows that end-customer sales
in China are picking up", says
Christian Kinch, CEO.
In June 2018, Bactiguard signed a
combined distribution and license agreement with Well Lead,
China's leading manufacturer of
consumable medical devices.
The first two product orders, at a combined value of
SEK 20 million, were part of the
initial contract and delivered in the second and fourth quarters of
2018. The third order, which has now been received, is worth
SEK 4,8 million and it is the first
order outside the initial contract.
This information is information that Bactiguard Holding AB
(publ) is obliged to make public pursuant to the EU Market Abuse
Regulation. The information was submitted for publication, through
the agency of the contact person set out below 2019-09-29, at
20:00.
For further information, please contact:
Cecilia Edström
CFO and deputy CEO
mobile: +46-722-262-328
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/bactiguard-holding-ab--publ-/r/new-major-order-from-china,c2920728
The following files are available for download:
|
https://mb.cision.com/Main/9686/2920728/1115431.pdf
|
190929 New major
order from China
|